- Epirubicin, etoposid a nízké dávky dexametazonu podávané každé dva týdny při hormonálně refrakterním karcinomu prostaty2003 | 1. lékařská fakulta
- Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia2012 | Lékařská fakulta v Hradci Králové
- Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia2016 | Lékařská fakulta v Hradci Králové
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study2019 | 1. lékařská fakulta
- Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer2003 | Lékařská fakulta v Hradci Králové
- Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study2022 | 1. lékařská fakulta
- Tacrolimus with high-dose dexamethasone pulses for chronic graft-versus-host disease managementPublikace bez příslušnosti k fakultě
- Bi.weekly eipirubicin and etoposide plus low dose dexamethasone (EED) for hormone-refractory prostate cancer (HRPC)Publikace bez příslušnosti k fakultě
- Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial2019 | 2. lékařská fakulta, 3. lékařská fakulta
- Combination of prednisolone and low dosed dexamethasone exhibits greater in vitro antileukemic activity than equiactive dose of prednisolone and overcomes prednisolone drug resistance in acute childhood lymphoblastic leukemia2014 | Lékařská fakulta v Plzni, 2. lékařská fakulta
- Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma2016 | Lékařská fakulta v Hradci Králové
- Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma2018 | 1. lékařská fakulta
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma2015 | Lékařská fakulta v Hradci Králové
- Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR2018 | 1. lékařská fakulta
- Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma2013 | 1. lékařská fakulta
- Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma2018 | 1. lékařská fakulta
- Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma2021 | 1. lékařská fakulta
- Short-term exercise combined with Acipimox administration induces an increase in plasma ACTH and its subsequent fall in the recovery phase in bulimic women2013 | 1. lékařská fakulta
- Postižení ledvin u mnohočetného myelomu a novinky v léčbě2015 | 1. lékařská fakulta
- Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma2016 | Publikace bez příslušnosti k fakultě
- Úspěšná léčba SAPHO syndromu (nebakteriální osteomyelitidy a akné) anakinrou a denosumabem. Popis případu a přehled léčebných možností2023 | 2. lékařská fakulta
- The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab2013 | Lékařská fakulta v Hradci Králové, 1. lékařská fakulta, Lékařská fakulta v Plzni
- A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma2015 | 1. lékařská fakulta
- Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN2017 | 3. lékařská fakulta